CA2587848A1 - Antiinfective lipopeptides - Google Patents

Antiinfective lipopeptides Download PDF

Info

Publication number
CA2587848A1
CA2587848A1 CA002587848A CA2587848A CA2587848A1 CA 2587848 A1 CA2587848 A1 CA 2587848A1 CA 002587848 A CA002587848 A CA 002587848A CA 2587848 A CA2587848 A CA 2587848A CA 2587848 A1 CA2587848 A1 CA 2587848A1
Authority
CA
Canada
Prior art keywords
amino
compound
formula
carbamoyl
protecting group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002587848A
Other languages
English (en)
French (fr)
Inventor
Dylan Christopher Alexander
Richard H. Baltz
Paul Brian
Marie-Francoise Coeffet-Le Gal
Sascha Doekel
Xiaowei He
Vidya Kulkarni
Christopher Leitheiser
Vivian Pak Woon Miao
Kien Trung Nguyen
Ian Barrie Parr
Daniel Ritz
Yanzhi Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cubist Pharmaceuticals LLC
Original Assignee
Cubist Pharmaceuticals, Inc.
Dylan Christopher Alexander
Richard H. Baltz
Paul Brian
Marie-Francoise Coeffet-Le Gal
Sascha Doekel
Xiaowei He
Vidya Kulkarni
Christopher Leitheiser
Vivian Pak Woon Miao
Kien Trung Nguyen
Ian Barrie Parr
Daniel Ritz
Yanzhi Zhang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharmaceuticals, Inc., Dylan Christopher Alexander, Richard H. Baltz, Paul Brian, Marie-Francoise Coeffet-Le Gal, Sascha Doekel, Xiaowei He, Vidya Kulkarni, Christopher Leitheiser, Vivian Pak Woon Miao, Kien Trung Nguyen, Ian Barrie Parr, Daniel Ritz, Yanzhi Zhang filed Critical Cubist Pharmaceuticals, Inc.
Publication of CA2587848A1 publication Critical patent/CA2587848A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002587848A 2004-11-12 2005-11-11 Antiinfective lipopeptides Abandoned CA2587848A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62705604P 2004-11-12 2004-11-12
US60/627,056 2004-11-12
US71070505P 2005-08-23 2005-08-23
US60/710,705 2005-08-23
PCT/US2005/040919 WO2006110185A2 (en) 2004-11-12 2005-11-11 Antiinfective lipopeptides

Publications (1)

Publication Number Publication Date
CA2587848A1 true CA2587848A1 (en) 2006-10-19

Family

ID=37087468

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002587848A Abandoned CA2587848A1 (en) 2004-11-12 2005-11-11 Antiinfective lipopeptides

Country Status (10)

Country Link
EP (1) EP1814588A2 (pt)
JP (1) JP2008519848A (pt)
KR (1) KR20070086038A (pt)
AU (1) AU2005330517A1 (pt)
BR (1) BRPI0517830A (pt)
CA (1) CA2587848A1 (pt)
IL (1) IL183109A0 (pt)
NO (1) NO20072634L (pt)
RU (1) RU2007121705A (pt)
WO (1) WO2006110185A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53152B (en) * 2008-12-22 2014-06-30 Cubist Pharmaceuticals Inc. NEW ANTIBACTERIAL AGENTS FOR TREATMENT OF Gram POSITIVE INFECTIONS
EP2714012A1 (en) * 2011-05-26 2014-04-09 Cubist Pharmaceuticals, Inc. Cb-183,315 compositions and related methods
KR101723649B1 (ko) 2014-10-23 2017-04-06 서울대학교산학협력단 신규한 펩티드 화합물, 이의 생산 방법, 및 이의 용도
CN113061164B (zh) * 2021-03-29 2023-01-10 四川大学 环脂肽类化合物及其在抗类风湿关节炎药物中的应用
WO2023152229A1 (en) * 2022-02-09 2023-08-17 Teitur Trophics Aps Novel peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001044271A2 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Daptomycin analogs and their use as antibacterial agents
EP1246838A1 (en) * 1999-12-15 2002-10-09 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
BR0017026A (pt) * 1999-12-15 2003-01-07 Cubist Pharm Inc Lipeptìdeos como agentes antibacterianos
NZ531493A (en) * 2001-08-06 2006-03-31 Cubist Pharm Inc Novel depsipeptides and process for preparing same, useful in the treatment of bacterial infection
EP1421097A4 (en) * 2001-08-06 2005-07-06 Cubist Pharm Inc COMPOSITIONS AND METHODS RELATING TO THE BIOSYNTHETIC MULTIGENIC FAMILY OF DAPTOMYCIN

Also Published As

Publication number Publication date
JP2008519848A (ja) 2008-06-12
WO2006110185A3 (en) 2007-10-25
EP1814588A2 (en) 2007-08-08
IL183109A0 (en) 2008-04-13
RU2007121705A (ru) 2008-12-20
WO2006110185A2 (en) 2006-10-19
AU2005330517A1 (en) 2006-10-19
BRPI0517830A (pt) 2008-10-21
KR20070086038A (ko) 2007-08-27
NO20072634L (no) 2007-08-09
AU2005330517A2 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
AU784755B2 (en) Daptomycin Analogs as antibacterial agents
AU784942B2 (en) Daptomycin analogs and their use as antibacterial agents
US20070128694A1 (en) Compositions and methods relating to the daptomycin biosynthetic gene cluster
US20040067878A1 (en) Novel lipopeptides as antibacterial agents
US20080051326A1 (en) Antiinfective Lipopeptides
CN101107265A (zh) 环状九肽酰胺类
CA2587848A1 (en) Antiinfective lipopeptides
JP2005531486A (ja) 新規のデプシペプチドおよびこれを調製するためのプロセス
EP2271665B1 (en) Highly bridged peptides from actinomadura namibiensis
CN101189253A (zh) 抗感染脂肽类
EP1421097A2 (en) Compositions and methods relating to the daptomycin biosynthetic gene cluster
EP1198470A1 (en) Pseudomycin prodrugs
EP1200460A1 (en) Pseudomycin n-acyl side-chain analogs
Zhang et al. Synthesis of two substrate mimics of thioesterase in the biosynthesis of cyclic depsipeptide WS9326A.
Tang et al. Global screening and genetic engineering of Tistrella enable sustainable production of didemnin drugs
EP1198472A1 (en) Amine-modified pseudomycin compounds

Legal Events

Date Code Title Description
FZDE Discontinued